CommScope benefits from secular tailwinds in AI data center cabling, DOCSIS 4.0 broadband upgrades, and WiFi 7-driven Ruckus ...
Immix Biopharma is advancing NXC-201, showing 95% complete/near-complete response rates and superior safety. Learn why IMMX ...
The Daily Overview on MSN
Hedge funds dumped Meta last quarter. Should you worry?
Hedge funds have been heading for the exits on Meta Platforms, unloading shares just as the stock has already taken a beating ...
Capital (XXI) lists on the NYSE as a Bitcoin-first Digital Asset Treasury (DAT), offering indirect Bitcoin exposure through a ...
Thank you, operator. Before we jump in, I want to remind you that today's call will contain forward-looking statements about ...
If the world is going to reach its target of tripling renewable energy capacity by 2030 (see No one left behind in the rooftop revolution), companies will need to pick up the pace in their purchases ...
In the January 2025 presentation, Jazz Pharmaceuticals expects zanidatamab to potentially receive approval and be launched as ...
Celiac disease represents a growing global health concern, with current management limited to lifelong adherence to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback